Skip to main content
. 2008 Apr 15;98(9):1536–1539. doi: 10.1038/sj.bjc.6604341

Figure 1.

Figure 1

Screening of specimens for EML4–ALK mRNA. Representative cases of lung, liver, and oesophageal carcinoma were subjected to reverse transcription-polymerase chain reaction with primers for EML4–ALK fusion transcript. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA is also shown. Marker, 100 bp DNA ladder.